Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 AUD | 0.00% |
|
-4.00% | +9.09% |
05:38am | PYC Therapeutics Completes Initial Dosing for Retinitis Pigmentosa Study | MT |
10/07 | PYC Therapeutics Begins Multiple Dose Trial for Blinding Eye Disease Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.09% | 38Cr | |
+25.83% | 4.8TCr | |
+0.69% | 4.24TCr | |
+44.64% | 4.15TCr | |
+30.52% | 3.16TCr | |
+22.30% | 2.86TCr | |
-6.35% | 2.8TCr | |
+49.25% | 1.46TCr | |
+49.18% | 1.41TCr | |
+3.45% | 1.26TCr |
- Stock Market
- Equities
- PYC Stock
- News PYC Therapeutics Limited
- PYC Therapeutics Completes Initial Dosing for Retinitis Pigmentosa Study